A single-arm, nonrandomized phase II trial of neoadjuvant gemcitabine and oxaliplatin in patients with resectable pancreas adenocarcinoma.
OʼReilly EM, Perelshteyn A, Jarnagin WR, Schattner M, Gerdes H, Capanu M, Tang LH, LaValle J, Winston C, DeMatteo RP, DʼAngelica M, Kurtz RC, Abou-Alfa GK, Klimstra DS, Lowery MA, Brennan MF, Coit DG, Reidy DL, Kingham TP, Allen PJ.
OʼReilly EM, et al. Among authors: schattner m.
Ann Surg. 2014 Jul;260(1):142-8. doi: 10.1097/SLA.0000000000000251.
Ann Surg. 2014.
PMID: 24901360
Free PMC article.
Clinical Trial.